🇺🇸 FDA
Patent

US 7227011

Nucleic acid vaccines for prevention of flavivirus infection

granted A61KA61K2039/53A61K2039/70

Quick answer

US patent 7227011 (Nucleic acid vaccines for prevention of flavivirus infection) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/53, A61K2039/70, A61K39/12, A61K48/00